ArticleJournal of endocrinological investigation2026

4-Methylumbelliferone for type 1 diabetes therapy: evidence for β-cell protection via EGFR/PI3K/Akt signaling.

Shuo Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.